Commitments and Contingent Liabilities (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Commitments and Contingencies Disclosure [Abstract] | |||
| Maturity date | February 28, 2024 | ||
| Expenses for lease of facilities | $ 283 | $ 237 | $ 236 |
| Research and development in process | $ 4,382 | ||
| Pay royalties | 3.00% | ||
| Maximum aggregate royalties paid | 100.00% | ||
| X | ||||||||||
- Definition Grants received for maximum aggregate royalties. No definition available.
|
| X | ||||||||||
- Definition Maturity date. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of operating lease expense. Excludes sublease income. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition. No definition available.
|
| X | ||||||||||
- Definition Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|